Search Within

Shakeel Modak

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (31)
  2. Meeting Abstract (19)
Groups
  1. Epidemiology and Biostatistics (50)
  2. Neuroblastoma Service (50)
  3. Pediatrics, Department of (50)
  4. GSK Faculty (43)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (42)
  6. Tow Center for Developmental Oncology (TCDO) (42)

More Groups

People
  1. Nai-Kong Cheung (35)
  2. Brian Kushner (33)
  3. Ellen Basu (24)
  4. Stephen Roberts (22)
  5. Audrey Mauguen (19)
  6. Kim Kramer (18)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (5)
  4. 2022 (5)
  5. 2021 (7)
  6. 2020 (2)

More Years

Publications
  1. Pediatric Blood and Cancer (13)
  2. Journal of Clinical Oncology (9)
  3. Cancer Research (3)
  4. OncoImmunology (3)
  5. Cancer (2)
  6. Clinical Cancer Research (2)

More Publications

Publishers
  1. Wiley Periodicals, Inc (13)
  2. American Society of Clinical Oncology (9)
  3. American Association for Cancer Research (6)
  4. Landes Bioscience (3)
  5. MDPI (2)
  6. Nature Publishing Group (2)

More Publishers

Results (50)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan: A Phase I study in patients with chemoresistant neuroblastoma
    Journal Article

    Modak, S.; Kushner, B. H.; Kramer, K.; Vickers, A.; Cheung, I. Y.; Cheung, N. K. V.
    OncoImmunology (2013)

    Fulltext@MSK | Save
  • Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte- macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission
    Journal Article

    Cheung, N. K. V.; Cheung, I. Y.; Kushner, B. H.; Ostrovnaya, I.; Chamberlain, E.; Kramer, K.; Modak, S.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment
    Journal Article

    Tarek, N.; Luduec, J. B. L.; Gallagher, M. M.; Zheng, J.; Venstrom, J. M.; Chamberlain, E.; Modak, S.; Heller, G.; Dupont, B.; Cheung, N. K. V.; more...
    Journal of Clinical Investigation (2012)

    Fulltext@MSK | Save
  • Differential impact of high-dose cyclophosphamide, topotecan, and vincristine in clinical subsets of patients with chemoresistant neuroblastoma
    Journal Article

    Kushner, B. H.; Kramer, K.; Modak, S.; Qin, L. X.; Cheung, N. K. V.
    Cancer (2010)

    Fulltext@MSK | Save
  • Hypothyroidism after 131I-monoclonal antibody treatment of neuroblastoma
    Journal Article

    Bhandari, S.; Cheung, N. K. V.; Kushner, B. H.; Kramer, K.; Modak, S.; Larson, S. M.; Yeh, S.; Heller, G.; Sklar, C. A.
    Pediatric Blood and Cancer (2010)

    Fulltext@MSK | Save
  • Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma
    Journal Article

    Kushner, B. H.; Kramer, K.; Modak, S.; Qin, L. X.; Yataghene, K.; Jhanwar, S. C.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2009)

    Fulltext@MSK | Save
  • Phase I study of the combination of anti-GD2 antibody 3F8 and barley-derived (1→3,1→4)-ß-D-glucan for patients with resistant neuroblastoma
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Kramer, K.; Vickers, A.; Cheung, N.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I study of the combination of anti-GD2 antibody 3F8 and barley-derived beta glucan for resistant neuroblastoma
    Meeting Abstract

    Modak, S.; Kushner, B.; Kramer, K.; Vickers, A.; Cheung, N. K.
    Pediatric Blood and Cancer (2007)

    Fulltext@MSK | Save
  • Rituximab therapy of lymphoma is enhanced by orally administered (1 → 3),(1 → 4)-D-β-glucan
    Journal Article

    Modak, S.; Koehne, G.; Vickers, A.; O'Reilly, R. J.; Cheung, N. K. V.
    Leukemia Research (2005)

    Fulltext@MSK | Save
  • Orally administered β-glucans enhance anti-tumor effects of monoclonal antibodies
    Journal Article

    Cheung, N. K. V.; Modak, S.; Vickers, A.; Knuckles, B.
    Cancer Immunology, Immunotherapy (2002)

    Fulltext@MSK | Save